Monteiro, I. M., Boksay, I., Auer, S. R., Torossian, C., Ferris, S. H., & Reisberg, B. (2001). Addition of a frequency weighted score to the behavioral pathology in 21. Alzheimer's Disease Rating Scale: The BEHAVE-AD-FW: Methodology and Reliability. European Psychiatry, 16, 5S-24S.

Schmitt, F. A., Ashford, W., Ernesto, C., Saxton, J., Schneider, L. S., Clark, C., Ferris, S. H., Mackell, J., Schafer, K., & Thal, L. J. (2000). The severe impairment battery: Concurrent validity and the assessment of longitudinal change in Alzheimer's disease. Alzheimer Disease and Associated Disorders, 11, S51-S56.

Golomb, J. & Ferris, S. H. (2000). Pathophygiologic heterogeneity or differences in premorbid vulnerability? Neurobiology of Aging, 21, 871-872.

Kluger, A., Ferris, S. H., Golomb, J., Mittelman, M. S., & Reisberg, B. (1999). Neuropsychological prediction of decline to dementia in nondemented elderly. Journal of Geriatric Psychiatry and Neurology, 12, 168-179.

Ferris, S. H. (1999). Cognitive Outcome Measures. Alzheimer Disease and Associated Disorders, 13, S140-S142.

Mohs, R.C., & Ferris, S.H. (1998). Measuring response to treatment in Alzheimer's disease: what constitutes meaningful change? International Journal of Geriatric Pharmacology, 1, S7-S14

Small, G.W., Rabins, P.V., Barry, P.P., Buckholtz, N.S., DeKosky, S.T., Ferris, S.H., Finkel, S.I., Gwyther, L.P., Khachaturian, Z.S., Lebowitz, B.D., McRae, T.D., Morris, J.C., Oakley, F., Schneider, L.S., Streim, J.E., Sunderland, T., Teri, L.A., & Tune, L.E. (1997). Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. Journal of the American Medical Association, 278, 1363-1371.

Ferris S. H., Mackell,. J.A., Mohs, R., Schneider, L.S., Galasko, D., Whitehouse, P., Schmitt, F.A., Sano, M., Thomas, R., Ernesto, C., Grundman, M., Schafer, K., Thal, L.J., & the Alzheimer’s Disease Cooperative Study. (1997). A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: Results of the instrument development project of the Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders, 11 (Suppl. 2), S1-S12.

Kluger, A., Gianutsos, J. G., Golomb, J., Ferris, S. H., George, A. E., Franssen, E., & Reisberg, B. (1997). Patterns of motor impairment in normal aging, mild cognitive decline and early Alzheimer's disease. Journal of Gerontology: Psychological Sciences, 52B, P28-P39.

Mittelman, M.S., Ferris, S.H., Shulman, E., Steinberg, G.& Levin, B. (1996). Family counseling and support post- pone nursing home placement of AD patients: Long-term results of a spouse-caregiver intervention study. Journal of the American Medical Association, 276, 1725-1731.

Golomb, J., Kluger, A., de Leon, M. J., Ferris, S. H., Mittelman, M., Cohen, J., & George, A. E. (1996). Hippocampal formation size predicts declining memory performance in normal aging. Neurology, 47, 810-813.

de Leon, M. J., George, A. E., Golomb, J., Tarshish, C., Convit, A., Kluger, A., de Santi, S., McRae, T., Ferris, S. H., Reisbrg, B., Ince, C., & Rusinek, H. (1996). Frequency of hippocampus atrophy in 405 normal elderly and Alzheimer's Disease patients. Neurobiology of Aging, 18, 1-11.

Thal, L.J., Carta, A., Clarke, W.R., Ferris, S.H., Friedland, R.P., Petersen, R.C., Pettegrew, J.W., Pfeiffer, Raskin, M.A., Sano, M., Tuszynski, M.H. & Woolson, R.F. (1996). A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer’s disease. Neurology, 47, 705-711.

Prichep, L. S., John, E. R., Ferris, S. H., Reisberg, B., Alper, K., Almas, M., & Cancro, R. (1994). Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiology of Aging, 15, 85-90.

Golomb, J., Kluger, A., de Leon, M., Ferris, S., Convit, A., Mittelman, M., Cohen, J., Rusinek, H., de Santi, S., & George, A. (1994). Hippocampal formation size in normal human aging:a correlate of delayed secondary memory performance. Learning and Memory, 1, 45-54.

Flicker, C., Ferris, S. H., Kalkstein, D., & Serby, M. (1994). A double-blind, placebo-controlled crossover study of ganglioside GM1 treatment for Alzheimer's disease. American Journal of Psychiatry, 151, 126-129.

Golomb, J., de Leon, M.J., George, A.E., Kluger, A., Tarshish, C. & Ferris, S.H. (1993). Hippocampal atrophy in normal aging: An association with recent memory impairment. Archives of Neurology, 50, 967-976.

de Leon, M.J., Golomb, J., George, A.E., Convit, A., Tarshish, C.Y., McRae, T., de Santi, S., Smith, G. & Ferris, S.H. (1993). The radiologic prediction of Alzheimer's disease: The atrophic hippocampal formation. American Journal of Neuroradiology, 14, 897-906.

Flicker, C., Serby, M. & Ferris, S.H. (1990). Scopolamine effects on memory, language, visuospatial praxis, and psychomotor speed. Psychopharmacology, 100, 243-250.

Flicker, C., Ferris, S.H., Crook, T. & Bartus, R.T. (1990). Impaired facial recognition memory in aging and dementia. Alzheimer Disease and Associated Disorders, 4, 43-54.

BOOKS

Crook, T., Bartus, R., Ferris, S. & Gershon, S. (1986). Treatment Development Strategies for Alzheimer's Disease. Madison (CT): Mark Powley Associates.

Crook, T., Ferris, S.H. & Bartus, R.T. (1983). Assessment in Geriatric Psychopharmacology. New Canaan (CT): Mark Powley Associates.

About the ADRC | For Patients & Families | For Professionals | Programs & Services
Newsletter | Contact Us | Home